Burial Insurance for Cancer Survivors
The 2-year cancer-free benchmark, guaranteed issue options during treatment, and skin cancer exemptions.
Key Takeaways
- Comparing 40+ A-rated carriers ensures you never overpay for life coverage.
- Pre-existing health conditions often qualify for level, day-one coverage with the right carrier.
- Our independent brokerage works directly for you — at no cost or added markup.
A past cancer diagnosis does not prevent you from obtaining quality life insurance or burial protection. Insurance companies evaluate cancer applications based on the cancer type, stage, treatment completion date, and years cancer-free. Today, millions of cancer survivors qualify for affordable, immediate life insurance without requiring a physical medical exam.
1. The Crucial 2-Year Benchmark for Cancer Survivors
In final expense and simplified issue whole life underwriting, the question is almost always phrased:"In the past 2 years, have you been diagnosed with, treated for, or taken medication for cancer?"
If your last chemotherapy, radiation, or surgery was completed more than 24 months ago, you can honestly answer "NO" to the cancer question on most final expense applications. You qualify for 100% day-one level benefits at standard whole life rates.
If you are currently receiving active treatment or are within the 2-year window, guaranteed issue whole life policies require zero health questions and guarantee approval, locking in coverage that transitions to full payout after 2 years.
2. Maintenance Medications: Tamoxifen & Anastrozole
A frequent area of confusion involves long-term oral hormonal therapies for breast cancer or prostate cancer survivors, such as Tamoxifen, Anastrozole (Arimidex), or Letrozole:
- Routine Maintenance Exception: Many progressive carriers (including Mutual of Omaha, Prosperity, and American Amicable) specifically exempt maintenance hormone blockers if primary tumor removal, chemo, and radiation ended over 2 years ago.
- Carrier Verification Matters: Some older or conservative carriers mistakenly classify Tamoxifen as active cancer treatment. An independent broker ensures your application goes only to carriers that correctly categorize preventative therapy.
3. Basal Cell & Squamous Cell Skin Cancer
Minor skin cancers — specifically Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) that were surgically excised in an outpatient setting — are almost universally excluded from the "cancer" definition on life insurance applications. If you had a basal cell spot removed, you can generally answer "No" to cancer questions and secure top-tier preferred or standard rates immediately.
4. How Legacy Life Solutions Protects Cancer Survivors
We match your specific cancer history, stage, and treatment completion date with the exact carrier whose underwriting guidelines are most generous. You never pay extra for coverage you could obtain at standard market rates.
Need personal guidance for your state or health condition?
Our team reviews all carrier and product options to find you the best rates with zero pressure.